Newsletter #2
3 years of growth
Three years of growth & the best is yet to come!
Movmedix is booming!
Three years of growth & the best is yet to come!
We are living through a pivotal time for Movmedix, marked both by new challenges and tremendous opportunities. The past few months have been rich in transformations, both for our industry and our company. We have successfully met the regulatory requirements of the market with agility and diligence, thanks to the commitment and expertise of each one of you. Today, our goals are focused on innovation and opening new markets, a crucial step that will help reinforce and sustain our leading position to achieve our ambitions in the coming years. Looking towards the future also means preparing for tomorrow's transformations: our industry is evolving rapidly, and our ability to innovate will be the key to our competitiveness. This is why, after three years of structuring the company to absorb growth, we are now investing in an innovation strategy and external growth to continue our mission: “providing innovative solutions based on cutting-edge technologies to reduce hospitalization and rehabilitation time, morbidity and infection risks, and pain”. Beyond our values of innovation, unity, know-how, and dynamism, at Movmedix, we firmly believe that success relies on strong core values: trust, integrity, teamwork, and responsibility. These values will continue to guide all our decisions and actions as we pursue sustainable and inclusive growth. In just 3 years, Movmedix has experienced exceptional growth. Find out more about the key highlights of the past year, and join us in celebrating this exciting journey!
About Movmedix
Driven by our vision to restore infinite mobility to patients suffering from soft tissue injuries, Movmedix continues to evolve toward becoming a global leader in sports medicine. With more than three decades of expertise, we have been at the forefront of the artificial ligament field — pioneering free-fibre technology and designing implants tailored to specific clinical indications.
Building on the strong legacy of our LARS® (Ligament Advanced Reinforcement System) product range, we remain committed to developing innovative and disruptive solutions that address the evolving needs of surgeons and improve patient outcomes worldwide.



